Clinical Trial Update: The Effect of Multiple Doses of Epanova® on the Multiple-Dose Pharmacokinetics of Simvastatin in Healthy Normal Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the effect of multiple doses of Epanova on the pharmacokinetics of simvastatin in healthy subjects; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• Epanova (icosapent ethyl)
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: AstraZeneca | Conditions: Hypertriglyceridemia | Phase 1 | Status: COMPLETED